Rapid Micro Biosystems reports preliminary Q4 revenue $8.2M, consensus $7.6M

The company said, “The Company expects record fourth quarter 2024 revenue of approximately $8.2 million, representing growth of approximately 30% compared to the prior-year period. It placed six new Growth Direct systems and completed the validation of four customer systems in the fourth quarter and now has over 160 cumulative systems placed and over 135 cumulative systems validated globally. The Company continues to expect a sequential improvement in fourth quarter 2024 gross margin compared to the third quarter of 2024.”